+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

United States Neurosurgical Products Market Outlook to 2033 - Dura Substitutes, Neuroendoscopes and Neurosurgical Drills

  • PDF Icon

    Report

  • 47 Pages
  • March 2025
  • Region: United States
  • GlobalData
  • ID: 6058727
The “United States Neurosurgical Products Market Outlook to 2033” is a comprehensive databook report, covering key market data on the United States Neurosurgical Products market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Neuroendoscopes, Dura Substitutes and Neurosurgical Drills

The United States Neurosurgical Products Market report provides key information and data on:

  • Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
  • 2023 company share and distribution share data for Neurosurgical Products Market.
  • Global corporate-level profiles of key companies operating within the United States Neurosurgical Products Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.

Scope

United States Neurosurgical Products is segmented as follows:

  • Neuroendoscopes
  • Dura Substitutes
  • Neurosurgical Drills

Reasons to Buy

The United States Neurosurgical Products Market report helps you to develop:

  • Business strategies by identifying the key market segments poised for strong growth in the future.
  • Market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • Understand the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Neurosurgical Products Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Neurosurgical Products Market, United States
3.1 Neurosurgical Products Market, United States, Revenue ($m), 2018-2033
3.1.1 Dura Substitutes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.2 Neuroendoscopes Market, United States, Revenue ($m), by Segment, 2018-2033
3.1.3 Neurosurgical Drills Market, United States, Revenue ($m), by Segment, 2018-2033
3.2 Neurosurgical Products Market, United States, Volume (Units), 2018-2033
3.2.1 Dura Substitutes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.2 Neuroendoscopes Market, United States, Volume (Units), by Segment, 2018-2033
3.2.3 Neurosurgical Drills Market, United States, Volume (Units), by Segment, 2018-2033
3.3 Neurosurgical Products Market, United States, Average Price ($), 2018-2033
3.4 Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), 2023
3.5 Neurosurgical Products Market, United States, Company Share by Revenue ($m), 2023
4 Overview of Key Companies in United States, Neurosurgical Products Market
4.1 Integra LifeSciences Corp
4.1.1 Company Overview
4.2 Medtronic Plc
4.2.1 Company Overview
4.3 B. Braun Melsungen AG
4.3.1 Company Overview
4.4 Stryker Corp
4.4.1 Company Overview
4.5 KARL STORZ SE & Co KG
4.5.1 Company Overview
4.6 DePuy Synthes Inc
4.6.1 Company Overview
4.7 Clearmind Biomedical Inc
4.7.1 Company Overview
4.8 Baxter International Inc
4.8.1 Company Overview
4.9 Regenity Biosciences
4.9.1 Company Overview
5 Neurosurgical Products Market Pipeline Products
6 Financial Deals Landscape
6.1 Debt Offerings
6.1.1 Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
6.1.2 Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
7 Recent Developments
7.1 Corporate Communications
7.1.1 Feb 28, 2024: Bob Azelby to Join Cardinal Health Board of Directors
7.2 Financial Announcements
7.2.1 Jan 27, 2025: Organogenesis Holdings to Report Fourth Quarter of Fiscal Year 2024 Financial Results on February 27, 2025
7.2.2 Dec 19, 2024: Cardinal Health to Announce Second-Quarter Results for Fiscal Year 2025 on January 30
7.2.3 Nov 01, 2024: Cardinal Health Announces Q1 Fiscal Year 2025 Results
7.2.4 Oct 17, 2024: ClearPoint Neuro to Announce Third Quarter 2024 Results November 7, 2024
7.2.5 Oct 01, 2024: Stryker to Announce Its Third Quarter 2024 Financial Results
7.2.6 Aug 14, 2024: Cardinal Health Reports Fourth Quarter and Fiscal Year 2024 Results and Raises Fiscal Year 2025 Guidance
7.2.7 Jul 17, 2024: ClearPoint Neuro to Announce Second Quarter 2024 Results August 7, 2024
7.2.8 Jul 15, 2024: Integra LifeSciences to Host Second Quarter 2024 Financial Results Conference Call on July 29, 2024
7.2.9 Jul 01, 2024: Stryker to Announce Financial Results for its Second Quarter of Fiscal Year 2024
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 The Publisher's Consulting
8.3 Contact the Publisher
8.4 Disclaimer
List of Tables
Table 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2018-2033
Table 5: Neurosurgical Products Market, United States, Volume (Units), 2018-2033
Table 6: Dura Substitutes Market, United States, Volume (Units), 2018-2033
Table 7: Neuroendoscopes Market, United States, Volume (Units), 2018-2033
Table 8: Neurosurgical Drills Market, United States, Volume (Units), 2018-2033
Table 9: Neurosurgical Products Market, United States, Average Price ($), 2018-2033
Table 10: Neurosurgical Products Market, United States, Distribution Share by Revenue ($m), USD Constant, 2023
Table 11: Neurosurgical Products Market, United States, Company Share by Revenue ($m), USD Constant, 2023
Table 12: Neurosurgical Products Market Pipeline Products
Table 13: Stryker Raises USD883.83 Million Public Offering of 3.375% Notes Due 2032
Table 14: Stryker Raises USD662.87 Million in Public Offering of 3.625% Notes Due 2036
Table 15: Total Number of Primary Research Participants, Neurology Devices Market, by Country
List of Figures
Figure 1: Neurosurgical Products Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 2: Dura Substitutes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 3: Neuroendoscopes Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 4: Neurosurgical Drills Market, United States, Revenue ($m), USD Constant, 2018-2033
Figure 5: Neurosurgical Products Market, United States, Volume (Units), 2018-2033
Figure 6: Dura Substitutes Market, United States, Volume (Units), 2018-2033
Figure 7: Neuroendoscopes Market, United States, Volume (Units), 2018-2033
Figure 8: Neurosurgical Drills Market, United States, Volume (Units), 2018-2033
Figure 9: Neurosurgical Products Market, United States, Company Share (%) 2023

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • B. Braun Melsungen AG
  • Baxter International Inc
  • Clearmind Biomedical Inc
  • DePuy Synthes Inc
  • Integra LifeSciences Corp
  • KARL STORZ SE & Co KG
  • Medtronic Plc
  • Regenity Biosciences
  • Stryker Corp